NOX 4.76% 11.0¢ noxopharm limited

Ann: Noxopharm 2021 AGM Corporate Presentation, page-8

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 392 Posts.
    lightbulb Created with Sketch. 132

    I agree that Pharmorage could be bigger than NOX. We would usually expect an IPO to occur, but in this case there is a possible alternative.

    The ability to make an mRNA vaccine with negligible side effects but stronger efficacy must be an attractive proposition to many companies. It is true that trials would need to confirm the mechanism of action, but it is also true that the technology has been invented by a world-leading institution which has been working on it for many years, but only entered into a License agreement after they had compiled sufficient pre-clinical evidence to justify a couple of patent applications.

    If I were a betting man, and I am, I would place money on the prospect that one or more companies will be willing to pay up-front License fees (perhaps with escalating amounts depending on the status of confirmatory trials), plus royalties, to see whether the technology will be compatible with their particular manufacturing technique.

    We would not need a great amount of money up-front to obviate the need for an IPO.

    That said, Noxopharm has to plan for the possibility that BMS or another company might try to buy Noxopharm outright. In that case, I expect Nyrada shares held by NOX would first be distributed to NOX shareholders on a pro-rata basis; and a similar thing to occur with Pharmorage. Noxopharm seems to think Pharmorage will be bigger then Ben Hur, so I expect NOX to do everything it can to ensure shareholders retain as much control of Pharmorage as is possible.

    Excellent post RBx….

    and a plan that I think will turn out to be not too far from that you have proffered mate.

    Just one other point that you will know but didn’t precisely spell out… is the bit in the written presentation (I think) that talks about …Also making vaccine production 30% plus more efficient?

    Obviously safety and efficacy are at the top of the list…. But… if into the bargain you can also make it cheaper and easier to produce a vaccine… that would be the perfect cherry on the cake!!

    Really looking forward to seeing and hearing AGM as it was broadcast live. By your description it was one of the best to date? Unfortunately I could not get into the live broadcast via the Automic link despite having an account and tuning in 20 minutes before. Very frustrating… but you and others have painted a great picture. I understand that a version of it will be on the NOX website soon.

    Thanks guys……. Apples

 
watchlist Created with Sketch. Add NOX (ASX) to my watchlist
(20min delay)
Last
11.0¢
Change
0.005(4.76%)
Mkt cap ! $32.14M
Open High Low Value Volume
11.5¢ 11.5¢ 11.0¢ $18.94K 171.9K

Buyers (Bids)

No. Vol. Price($)
1 50000 11.0¢
 

Sellers (Offers)

Price($) Vol. No.
12.5¢ 66800 1
View Market Depth
Last trade - 14.48pm 08/11/2024 (20 minute delay) ?
NOX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.